Tereza Lopotová

发表

Hsp90 - a potential prognostic marker in CML.

H. Klamová, J. Moravcová, M. Žáčková, 2013, Blood cells, molecules & diseases.

High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain.

H. Klamová, J. Moravcová, K. Polakova, 2008, Leukemia research.

Expression patterns of microRNAs associated with CML phases and their disease related targets

H. Klamová, T. Stopka, J. Moravcová, 2011, Molecular Cancer.

Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs.

H. Klamová, J. Moravcová, J. Schwarz, 2012, Blood cells, molecules & diseases.

N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia.

H. Klamová, J. Moravcová, J. Schwarz, 2012, Leukemia research.

MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?

H. Klamová, J. Moravcová, Tereza Lopotová, 2011, Leukemia research.

Differential Expression of miRNAs during the Course of Chronic Myeloid Leukemia.

H. Klamová, J. Moravcová, K. Polakova, 2008 .

MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?

H. Klamová, J. Moravcová, Tereza Lopotová, 2011, Leukemia research.

High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain.

H. Klamová, J. Moravcová, K. Polakova, 2008, Leukemia research.

Hsp90 - a potential prognostic marker in CML.

H. Klamová, J. Moravcová, D. Moučková, 2013, Blood cells, molecules & diseases.